| Primary |
| Diabetes Mellitus |
82.7% |
| Type 2 Diabetes Mellitus |
7.3% |
| Drug Use For Unknown Indication |
6.3% |
| Product Used For Unknown Indication |
1.2% |
| Diabetes Mellitus Non-insulin-dependent |
0.7% |
| Urinary Tract Infection |
0.3% |
| Hypertension |
0.2% |
| Blood Glucose |
0.2% |
| Atrial Fibrillation |
0.1% |
| Blood Pressure |
0.1% |
| Furuncle |
0.1% |
| Hypercholesterolaemia |
0.1% |
| Nutritional Support |
0.1% |
| Polycystic Ovaries |
0.1% |
| Product Contamination |
0.1% |
| Prophylaxis |
0.1% |
| Blood Glucose Increased |
0.1% |
| Erectile Dysfunction |
0.1% |
| Infection |
0.1% |
| Secondary Immunodeficiency |
0.1% |
|
| Myocardial Infarction |
31.0% |
| Death |
23.2% |
| Cerebrovascular Accident |
10.8% |
| Myocardial Ischaemia |
10.7% |
| Cardiac Failure Congestive |
5.8% |
| Injury |
3.8% |
| Coronary Artery Disease |
1.9% |
| Transient Ischaemic Attack |
1.5% |
| Cardiac Disorder |
1.3% |
| Coronary Artery Bypass |
1.3% |
| Cardiovascular Disorder |
1.2% |
| Hypertension |
1.1% |
| Renal Failure |
1.1% |
| Pain |
1.0% |
| Weight Increased |
0.9% |
| Dyspnoea |
0.8% |
| Liver Injury |
0.8% |
| Adverse Event |
0.7% |
| Heart Injury |
0.7% |
| Arteriosclerosis |
0.6% |
|
| Secondary |
| Diabetes Mellitus |
36.2% |
| Drug Use For Unknown Indication |
26.7% |
| Type 2 Diabetes Mellitus |
18.3% |
| Diabetes Mellitus Non-insulin-dependent |
4.0% |
| Renal Cell Carcinoma |
2.1% |
| Bladder Cancer |
1.9% |
| Completed Suicide |
1.3% |
| Hypercholesterolaemia |
1.3% |
| Hypertension |
1.3% |
| Dyslipidaemia |
1.1% |
| Metabolic Disorder |
1.1% |
| Anxiety |
0.5% |
| Blood Cholesterol Increased |
0.5% |
| Blood Glucose |
0.5% |
| Depression |
0.5% |
| Diabetic Retinal Oedema |
0.5% |
| Gastrooesophageal Reflux Disease |
0.5% |
| High Density Lipoprotein Decreased |
0.5% |
| Lipids Abnormal |
0.5% |
| Metastatic Neoplasm |
0.5% |
|
| Myocardial Infarction |
22.1% |
| Weight Fluctuation |
10.7% |
| Myocardial Ischaemia |
9.9% |
| Myalgia |
7.6% |
| Granulomatous Liver Disease |
6.1% |
| Cardiac Failure Congestive |
5.3% |
| Pulmonary Oedema |
5.3% |
| Cerebrovascular Accident |
4.6% |
| Coronary Artery Disease |
3.8% |
| High Density Lipoprotein Decreased |
3.8% |
| Oedema |
3.1% |
| Stent Placement |
3.1% |
| Foetal Growth Retardation |
2.3% |
| Hypoglycaemia |
2.3% |
| Transient Ischaemic Attack |
2.3% |
| Cardiovascular Disorder |
1.5% |
| Death |
1.5% |
| Diabetes Mellitus Inadequate Control |
1.5% |
| Ear Pain |
1.5% |
| Ischaemic Cardiomyopathy |
1.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
37.3% |
| Diabetes Mellitus |
16.3% |
| Hypertension |
8.9% |
| Rheumatoid Arthritis |
4.9% |
| Hiv Infection |
4.3% |
| Hypercholesterolaemia |
4.0% |
| Hiv Test Positive |
2.6% |
| Blood Cholesterol |
2.2% |
| Depression |
2.1% |
| Hyperlipidaemia |
2.1% |
| Type 2 Diabetes Mellitus |
2.0% |
| Anxiety |
1.9% |
| Blood Pressure |
1.8% |
| High Density Lipoprotein Decreased |
1.7% |
| Insomnia |
1.6% |
| Blood Cholesterol Increased |
1.5% |
| Cardiac Disorder |
1.5% |
| Vitamin Supplementation |
1.2% |
| Blood Triglycerides Increased |
1.1% |
| Hypopituitarism |
1.1% |
|
| Hyperhidrosis |
8.5% |
| Nausea |
8.5% |
| Weight Decreased |
7.5% |
| Dyspnoea |
6.6% |
| Vomiting |
6.6% |
| Weight Increased |
6.6% |
| Tremor |
5.7% |
| Troponin Increased |
5.7% |
| Leukopenia |
4.7% |
| Rhabdomyolysis |
4.7% |
| Skin Ulcer |
4.7% |
| Incorrect Dose Administered |
3.8% |
| Myalgia |
3.8% |
| Pneumonia |
3.8% |
| Stress Ulcer |
3.8% |
| Thrombosis |
3.8% |
| Blood Human Chorionic Gonadotropin Abnormal |
2.8% |
| International Normalised Ratio Increased |
2.8% |
| Pain |
2.8% |
| Somnolence |
2.8% |
|
